FILOMIA, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 1.907
NA - Nord America 1.361
AS - Asia 819
SA - Sud America 223
AF - Africa 26
OC - Oceania 2
Totale 4.338
Nazione #
US - Stati Uniti d'America 1.340
RU - Federazione Russa 1.025
SG - Singapore 314
CN - Cina 234
PL - Polonia 218
BR - Brasile 190
IE - Irlanda 187
IT - Italia 150
SE - Svezia 117
HK - Hong Kong 85
DE - Germania 57
VN - Vietnam 55
FR - Francia 37
IN - India 36
GB - Regno Unito 34
FI - Finlandia 25
AR - Argentina 12
BE - Belgio 12
ZA - Sudafrica 11
ID - Indonesia 10
NL - Olanda 10
BD - Bangladesh 9
AT - Austria 8
ES - Italia 8
PK - Pakistan 8
JP - Giappone 7
MX - Messico 7
PH - Filippine 7
UZ - Uzbekistan 7
CA - Canada 6
CO - Colombia 6
TR - Turchia 6
AZ - Azerbaigian 5
EC - Ecuador 5
BZ - Belize 4
CI - Costa d'Avorio 4
DZ - Algeria 4
IL - Israele 4
IQ - Iraq 4
MA - Marocco 4
SA - Arabia Saudita 4
VE - Venezuela 4
CZ - Repubblica Ceca 3
IR - Iran 3
KW - Kuwait 3
LT - Lituania 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
OM - Oman 2
PE - Perù 2
UA - Ucraina 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GD - Grenada 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 4.338
Città #
Moscow 320
Ashburn 291
Warsaw 216
Dallas 208
Dublin 187
Singapore 180
Chandler 139
Nyköping 87
Hong Kong 85
San Jose 71
Messina 66
Beijing 51
The Dalles 46
Dearborn 40
Ann Arbor 35
Munich 31
Los Angeles 28
Lauterbourg 22
Princeton 22
Council Bluffs 20
Medford 20
Jacksonville 16
Ho Chi Minh City 15
New York 15
Des Moines 14
Redondo Beach 14
São Paulo 14
Turku 14
Cambridge 13
Santa Clara 13
Brussels 12
Dong Ket 12
Seattle 12
Tianjin 12
Hyderabad 11
Nanjing 11
Orem 11
Catania 10
Guangzhou 10
Jinan 10
Avola 9
Buffalo 9
Hanoi 9
Chennai 8
Jakarta 8
Nuremberg 8
Rio de Janeiro 8
Amsterdam 7
Brooklyn 7
Frankfurt am Main 7
London 7
Pune 7
Tokyo 7
Boardman 6
Bremen 6
Hangzhou 6
Johannesburg 6
San Mateo 6
Shenzhen 6
Stockholm 6
Wilmington 6
Baku 5
Cagliari 5
Curitiba 5
Haikou 5
Houston 5
Rome 5
Shenyang 5
Tashkent 5
Abidjan 4
Barnet 4
Cape Town 4
Denver 4
Hebei 4
Helsinki 4
Mexico City 4
Mumbai 4
Nanchang 4
Poplar 4
San Francisco 4
Shanghai 4
Vienna 4
Woodbridge 4
Zhengzhou 4
Atlanta 3
Baghdad 3
Belo Horizonte 3
Brasília 3
Chicago 3
Guarulhos 3
Guayaquil 3
Ijuí 3
Islamabad 3
Joinville 3
Kuwait City 3
Lahore 3
Ningbo 3
Ninh Bình 3
Serra 3
Sorocaba 3
Totale 2.701
Nome #
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma development and death in patients with compensated cirrhosis 324
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 266
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 264
Atrial fibrillation in patients with cirrhosis 244
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 209
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 207
Erectile dysfunction in compensated liver cirrhosis 197
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 188
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 188
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 180
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 166
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 160
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 159
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy 158
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 131
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 130
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 128
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 126
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series 121
Detection of SARS-CoV-2 in Ascitic Fluid of Cirrhotic COVID-19 Patients: Case Series and Literature Review 114
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 111
Occult HBV infection 109
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 107
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 107
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 84
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 81
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world 53
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 45
RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study 39
null 22
null 20
Totale 4.438
Categoria #
all - tutte 13.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 32 3 12
2021/2022165 6 15 5 7 15 0 19 9 0 13 25 51
2022/2023492 36 65 18 38 28 45 11 29 208 4 8 2
2023/2024146 12 14 7 17 15 26 1 12 0 20 4 18
2024/2025697 11 27 13 44 36 25 41 110 156 49 79 106
2025/20262.392 125 185 179 144 182 521 285 310 343 118 0 0
Totale 4.438